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A mutant of Myco6acterium smegmatis defective in mycolic acid biosynthesis was isolated following chemical 
mutagenesis. Fatty acids were extracted from the mutant and subjected to structural analysis by thin-layer 
chromatography and high-performance liquid chromatography (HPLC) of both methyl and p-bromophenacyl 
ester derivatives. Thin-layer chromatography did not show the presence of any fatty acid of RF comparable to that 
of standard methyl mycolate. The HPLC profile revealed a broad peak in the standard mycolic acid ester region. 
No characteristic peaks of mycolic acid esters comparable to the wild-type could be resolved. Mass spectral 
analysis of the HPLC-purified peak demonstrated the presence of shorter-chain fatty acids in the mutant. These 
data support the idea that the mutant accumulates precursors of mycolic acids and is incapable of carrying out the 
final conversion to mycolic acids of 60-90 carbon atoms. 
Introduction 
Mycolic acids are a-alkyl-P-hydroxy fatty acids unique to 
mycobacteria, nocardiae and corynebacteria (Gray et al., 
1982; Kaneda et al., 1988; Minnikin & Goodfellow, 
1980; Minnikin et al., 1980; Qureshi et al., 1978; 
Ratledge, 1982). They are major cell wall constituents. 
The number of carbon atoms which make up the mycolic 
acids varies from 60 to 90 in the genus Mycobacterium 
(Gray et al., 1982; Kaneda et al., 1988; Minnikin et al., 
1980). The basic structure is R1 CH(OH)CH(R,)COOH, 
where R2 is a linear alkane (C2,-C2J and R1 is a 
complex structure comprising about 60 carbon atoms 
and containing different functional groups including 
hydroxyl, methoxyl, carbonyl and carboxyl groups, 
cyclopropane rings, methyl branches and carbon double 
bonds (Steck et al., 1978). Mycolic acids may play an 
important role in the pathogenicity of mycobacteria, 
since antituberculous drugs have been shown to inhibit 
mycolic acid biosynthesis (Takayama et al., 1975), 
making it important to elucidate the pathway of mycolic 
acid biosynthesis. 
Mycobacterium smegmatis, a rapidly growing cultiva- 
ble mycobacterium, has been widely used to study 
mycobacterial metabolism (David, 1977; Matula et al., 
1971) and the biosynthesis of C16-C32 fatty acids in M. 
smegmatis has been studied with cell-free extracts (Bloch 
& Vance, 1977). Lacave et al. (1990) have also 
established a cell-free system capable of synthesizing 
whole mycolic acid in M. aurum. The general structure of 
mycolic acids suggests a Claisen-like condensation 
reaction between two aliphatic chains. However, the 
details of the steps involved are still largely unknown 
(Takayama & Qureshi, 1984). We have isolated a mutant 
of M. smegmatis defective in synthesis of high-molecular- 
mass (C60-C90) fatty acids. This may be of considerable 
importance in studying mycolic acid biosynthesis. This is 
the first report of a mycobacterial mutant defective in 
mycolic acid synthesis. 
Methods 
Isolation of a penicillin-sensitive mutant. Mycobacterium smegmatis 
SN2 was grown in nutrient broth. Cells grown to early exponential 
phase were suspended in 50 mwpotassium phosphate buffer, pH 6.5, 
containing N-methyl-N'-nitro-N-nitrosoguanidine (NTG), and incu- 
bated at 37 "C for 1 h. The cells were then harvested, washed to remove 
NTG under sterile conditions and serially diluted. The diluted 
suspensions were plated on solid nutrient broth (containing, 1-l: beef 
extract 10 g, peptone 10 g, NaCl5 g; and 2%, w/v, agar) and incubated 
for 5 d. Mutants were selected for penicillin sensitivity by replica 
plating using different concentrations of penicillin G in the growth 
medium. A penicillin-sensitive mutant was finally picked using a 
single-colony selection procedure. Biochemical tests specific for M .  
smegmatis (Standard taxonomic tests; US Department of Health and 
Human Services, 1980) were carried out on the mutant and the wild- 
type. The arylsulphatase assay was carried out using pnitrocatechol 
sulphate as a substrate. Catalase activity was measured by using 
hydrogen peroxide. For the nitrate reduction test, the mutant and the 
wild-type were grown in nitrate agar (containing 0.1 % KN03) and the 
change in colour examined after addition of sulphanilic acid to the 
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medium. Iron uptake was studied by growing the organism in a 
medium containing 2.5% (w/v) ferric ammonium citrate and following 
the change in colour of the medium. Arabinogalactan, a characteristic 
cell wall component of mycobacteria, was isolated and analysed by gas- 
liquid chromatography after hydrolysis as described previously (Kundu 
et al., 1990). 
Isolation offutty acids. These were isolated using a modification of 
the method described by Lankelle et al. (1988). The cells were extracted 
with chloroform/methanol (2 : 1, v/v), washed with the same solvent, 
treated with tetrabutylammonium hydroxide overnight at 100 "C, then 
acidified with 6 M-HCl. Fatty acids were extracted from the reaction 
mixture using light petroleum (b.p. 40-60 "C). 
Preparation of fatty acid methyl esters. The extracted fatty acids were 
methylated using ethereal diazomethane and dried. Methyl esters of 
fatty acids were spotted on to a silica gel GHL plate (Analtech) and 
developed with light petroleum/diethyl ether/acetic acid (9 : 1 : 0-2, by 
vol.). Spots on the plates were then visualized either by iodine vapour or 
by a dichromate and hot sulphuric acid spray. 
Preparation of p-bromophenacyl esters of mycolic acids. These were 
prepared by the method of Butler & Kilburn (1988). Cells were 
extracted with 25% (w/v) KOH in ethanol/water (1 : 1, v/v) at 85 "C. 
The extract was then treated with chloroform, acidified with 
concentrated HCl, dried, treated with potassium bicarbonate and 
again dried. p-Bromophenacyl/crown ether mix (Pierce Chemical Co.) 
was added in 10-fold molar excess, heated at 85 "C for 20 min, filtered 
and the supernatant evaporated under vacuum. 
Analysis ofp-bromophenacyl esters of mycolic acids. High-performance 
liquid chromatography (HPLC) was performed on a Waters Associates 
model 6000A liquid chromatograph equipped with a variable- 
wavelength detector (model LC-85B; Perkin-Elmer) measuring absor- 
bance at 254nm. The mycolic acid p-bromophenacyl esters were 
applied to a 10 Fm particle size Waters cartridge C,8 reverse-phase 
column equilibrated with 91 % methanol/9% chloroform. After 
injection of the sample, the gradient was changed linearly to 30% 
methanol/70% chloroform over a period of 65 min at a total flow rate of 
2 ml min-' (Butler et al., 1986). Mass spectra were recorded on a 
ultrahigh resolution mass spectrometer, MS-5OTC (Kratos Analytical 
Instruments) fitted with a D5-55 data acquisition system. Spectra were 
obtained at 70 eV ionization potential and 300 pA emission current. 
Results 
The colonies of the wild-type were rough and wrinkled 
whereas those of the penicillin-sensitive mutant were 
smooth and filamentous. Both the wild-type and the 
mutant satisfied the biochemical tests characteristic of 
M. smegmatis, i.e. positive for catalase (68 "C), amidase, 
nitrate reduction, iron uptake and presence of arabinoga- 
lactan, and negative for arylsulphatase. The mutant and 
the wild-type both contained arabinogalactan, a charac- 
teristic cell surface component of mycobacteria. Thin- 
layer chromatography of the methyl esters of fatty acids 
isolated from both the wild-type and the mutant cells 
after chloroform/methanol extraction was carried out 
using standard methyl mycolate from M. smegmatis (a 
generous gift from Dr K. Takayama). No methyl 
mycolate corresponding to the standard was obtained in 
the case of the mutant (Fig. 1). 
Fig. 1. Thin-layer chromatography of methyl mycolates of wild type 
M .  smegmatis and its mutant: A, wild type; B, standard methyl 
mycolate; C, mutant. 
Preparations of the p-bromophenacyl esters of mycolic 
acids from the mutant and the wild-type were dissolved 
in a minimum amount of chloroform/methanol (91 :9, 
v/v) and injected into a reverse-phase column as 
described in Methods. A number of peaks, characteristic 
of the mycolates from M. smegmatis (Takayama & 
Qureshi, 1984), were obtained in the case of the wild-type 
cells. The peaks eluted between 36 and 48 min at a flow 
rate of 2 ml min-l (Fig. 2a). For the mutant, however, 
only one broad peak was obtained (Fig. 2b). The fraction 
eluting between 36 and 48 min from the HPLC column 
was subjected to mass spectrometry. About 15-20 peaks 
in the M ,  range 800-1200 were obtained in the case of the 
wild-type, while in the case of the mutant, a number of 
peaks of significantly lower M ,  (600-850) were observed 
(data not shown). 
Discussion 
Earlier studies have indicated that mycolic acid biosyn- 
thesis might be the target of some antituberculous drugs 
(Takayama et al., 1975). We have isolated a mutant of M. 
smegmatis defective in mycolic acid biosynthesis. The 
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Fig. 2. HPLC profile of p-bromophenacyl esters of mycolic acid from 
(a)  wild-type, (b) mutant. 
mutant is taxonomically a mycobacterium on the basis of 
biochemical tests and by the presence of arabinogalac- 
tan, a typical cell wall polysaccharide of mycobacteria. 
Thin-layer chromatography indicated the absence of 
methyl mycolates characteristic of M .  smegmatis. Mass 
spectrometry of the mycolic acid p-bromophenacyl esters 
revealed the accumulation of shorter-chain fatty acids in 
the mutant, in contrast to the c60-cgO fatty acids 
characteristic of the wild-type. These data suggest that 
the mutant is defective in mycolic acid biosynthesis. 
Biosynthesis of mycolic acids in mycobacteria in- 
volves several steps. Elongation and Claisen-like con- 
densation reactions between aliphatic chains occur with 
several intermediate reactions such as transacylation, 
carboxylation, reduction, dehydration and desaturation. 
In M .  smegmatis the newly synthesized mycolic acids 
have been reported to be transferred to final cell wall 
products via a mycolic acid exchange enzyme (Sathya- 
moorthy & Takayama, 1987). However, the biosynthetic 
machinery responsible for mycolic acid formation 
remains poorly understood. Qureshi et al. (1978) have 
identified two structural series of C28: 1-C42: and CS5 :2  
meromycolic acids as possible precursors of monoenyl 
and dienyl mycolic acids respectively, since these acids 
are structurally related to the a-alkylhydroxyl group of 
the corresponding mycolic acid of M .  smegmatis (Sathya- 
moorthy et al., 1985). On the basis of the structures of 
different precursor fatty acids such as the C41, c43-c56 
series, a possible pathway covering the precursor- 
product relationship between the c24-c56 fatty acids 
and a-mycolic acids has been proposed by Takayama & 
Qureshi (1984). In this scheme c 2 4 - 3 2  esters undergo a 
series of reactions involving elongation, desaturation and 
cyclopropane ring formation to yield the a-meromycolic 
acid esters (CS2 or CS4 esters). These products serve as 
the alkyl acceptor in the subsequent condensation 
reaction with another molecule of C24 or c26 fatty acid 
ester. However, present knowledge is not sufficient to 
establish a rigid relationship among the steps of the 
proposed pathway described above. The accumulation of 
shorter-chain fatty acids, possibly the precursors of 
mycolic acids, in the mutant suggests a block in the 
condensation between R, -COOH (meromycolic acids) 
and the a-carbon of a C24-C26 fatty acid. The purifica- 
tion, and subsequent characterization by mass spectro- 
metry, of the individual components accumulating in the 
mutant will therefore be very useful in future studies 
involving detailed characterization of the intermediates 
present and their final conversion into mycolic acids. 
This will help to establish the different steps in the 
proposed pathway of mycolic acid biosynthesis. 
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